2020
DOI: 10.1016/j.bbrc.2020.03.117
|View full text |Cite
|
Sign up to set email alerts
|

Sennoside A restores colonic barrier function through protecting colon enterocytes from ROS-induced mitochondrial damage in diet-induced obese mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 23 publications
0
8
0
Order By: Relevance
“…Excessive production of ROS can cause mitochondrial damage and affect mitochondrial membrane potential ( Ma et al, 2020 ). Therefore, changes in mitochondrial membrane potential of MCF-7 cells were detected at 4, 8 and 12 h. As shown in Figures 5B,C , neither metformin alone nor TW80-SeNPs alone caused any significant change in mitochondrial membrane potential at 4 h, but after treatment with TW80-SeNPs combined with metformin, the JC-1 value increased to 25.79% compared with 0.19% in the control group.…”
Section: Resultsmentioning
confidence: 99%
“…Excessive production of ROS can cause mitochondrial damage and affect mitochondrial membrane potential ( Ma et al, 2020 ). Therefore, changes in mitochondrial membrane potential of MCF-7 cells were detected at 4, 8 and 12 h. As shown in Figures 5B,C , neither metformin alone nor TW80-SeNPs alone caused any significant change in mitochondrial membrane potential at 4 h, but after treatment with TW80-SeNPs combined with metformin, the JC-1 value increased to 25.79% compared with 0.19% in the control group.…”
Section: Resultsmentioning
confidence: 99%
“…42 For example, Sen A is commonly used as an irritant laxative in the clinical scenario and potently decreases α-glucoamylase enzymatic activity and further ameliorates type 2 diabetes and obesity. 43,44 Sen A also shows potential to be applied as an anti-tumor drug with a modulatory effect on the slingshot family proteins as well as Wnt and VEGF-signaling pathways that are involved in cancer…”
Section: Discussionmentioning
confidence: 99%
“…42 For example, Sen A is commonly used as an irritant laxative in the clinical scenario and potently decreases α-glucoamylase enzymatic activity and further ameliorates type 2 diabetes and obesity. 43,44 Sen A also shows potential to be applied as an anti-tumor drug with a modulatory effect on the slingshot family proteins as well as Wnt and VEGF-signaling pathways that are involved in cancer metastasis. 45,46 Moreover, a recent study shed light on Sen A's beneficial properties in liver fibrosis by restraining DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation, and the loss of PTEN contributes to a decreased level of apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…Once the impairment of intestinal barrier occurs, harmful substances, such as endotoxin and microbiota, may enter the circulation, resulting in chronic low-grade inflammation ( Tilg et al, 2020 ). Some recent studies have suggested that SA may protect the function of intestinal barrier ( Ma et al, 2020a ; Wei et al, 2020 ). Ma et al reported that SA (30 mg/kg) could protect colon enterocytes from ROS toxicity and restore colonic barrier function, thereby improving insulin sensitivity induced low-grade chronic inflammation ( Ma et al, 2020a ).…”
Section: Pharmacologymentioning
confidence: 99%
“…Some recent studies have suggested that SA may protect the function of intestinal barrier ( Ma et al, 2020a ; Wei et al, 2020 ). Ma et al reported that SA (30 mg/kg) could protect colon enterocytes from ROS toxicity and restore colonic barrier function, thereby improving insulin sensitivity induced low-grade chronic inflammation ( Ma et al, 2020a ). Similarly, Wei et al suggested that SA (25, 50 mg/kg) decreased tissue inflammation by upregulating ZO-1 and occludin protein levels and protecting intestinal barrier function ( Wei et al, 2020 ).…”
Section: Pharmacologymentioning
confidence: 99%